Research analysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research note issued on Sunday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Price Performance BTX stock opened at $2.32 on Friday. Brooklyn ImmunoTherapeutics has a fifty-two week low of $0.17 and a fifty-two week […]